These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma. Scheid C; Pettengell R; Ghielmini M; Radford JA; Morgenstern GR; Stern PL; Crowther D Bone Marrow Transplant; 1995 Jun; 15(6):901-6. PubMed ID: 7581089 [TBL] [Abstract][Full Text] [Related]
4. Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection. El-Chennawi FA; Al-Tonbary YA; Mossad YM; Ahmed MA Hematology; 2008 Aug; 13(4):203-9. PubMed ID: 18796245 [TBL] [Abstract][Full Text] [Related]
5. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group. Ek T; Mellander L; Andersson B; Abrahamsson J Pediatr Blood Cancer; 2005 May; 44(5):461-8. PubMed ID: 15558707 [TBL] [Abstract][Full Text] [Related]
6. Clinical analysis of immune reconstitution after chemotherapy in children with acute lymphoblastic leukemia. Xu Y; Zhang A; Liu A; Hu Q BMC Pediatr; 2024 Aug; 24(1):557. PubMed ID: 39215273 [TBL] [Abstract][Full Text] [Related]
7. The effect of short-course high-dose methylprednisolone on peripheral blood lymphocyte subsets in children with acute leukemia during remission induction treatment. Tunç B; Oner AF; Hiçsönmez G Leuk Res; 2003 Jan; 27(1):19-21. PubMed ID: 12479848 [TBL] [Abstract][Full Text] [Related]
8. Cellular immunosuppression in children with acute lymphoblastic leukemia: effect of consolidation chemotherapy. Komada Y; Zhang SL; Zhou YW; Hanada M; Shibata T; Azuma E; Sakurai M Cancer Immunol Immunother; 1992; 35(4):271-6. PubMed ID: 1511462 [TBL] [Abstract][Full Text] [Related]
9. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies. Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295 [TBL] [Abstract][Full Text] [Related]
10. [Is cellular immunity not impaired after remission induction in acute lymphoblastic leukemia in children]. Łuczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Kasprzycka E; Zak J; Nowakowska M Pol Merkur Lekarski; 2004 Jan; 16(91):17-21. PubMed ID: 15080084 [TBL] [Abstract][Full Text] [Related]
11. Decrease in number of CD16(Leu 11)+CD45RA(2H4)+ cells and defective production of natural killer cytotoxic factor in childhood acute lymphoblastic leukemia. Yamada S; Komiyama A Leuk Res; 1991; 15(9):785-90. PubMed ID: 1833597 [TBL] [Abstract][Full Text] [Related]
12. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia]. Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587 [TBL] [Abstract][Full Text] [Related]
13. Reduced versus intensive chemotherapy for childhood acute lymphoblastic leukemia: impact on lymphocyte compartment composition. van Tilburg CM; van der Velden VH; Sanders EA; Wolfs TF; Gaiser JF; de Haas V; Pieters R; Bloem AC; Bierings MB Leuk Res; 2011 Apr; 35(4):484-91. PubMed ID: 21051085 [TBL] [Abstract][Full Text] [Related]
14. Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia - a prospective study of 20 paediatric patients. Eyrich M; Wiegering V; Lim A; Schrauder A; Winkler B; Schlegel PG Br J Haematol; 2009 Nov; 147(3):360-70. PubMed ID: 19694715 [TBL] [Abstract][Full Text] [Related]
15. Increased natural killer cell activity and numbers of Leu-7 and Leu-11b (CD 16)-positive cells in bone marrow of children in remission from acute lymphoblastic leukaemia. Sørskaar D; Førre O; Lie SO Scand J Immunol; 1989 Jan; 29(1):65-72. PubMed ID: 2466327 [TBL] [Abstract][Full Text] [Related]
17. Immunologic effects of intermediate-dose IL-2 i.v. after autologous hematopoietic cell transplantation in pediatric solid tumors. Kalwak K; Ussowicz M; Gorczyńska E; Turkiewicz D; Toporski J; Dobaczewski G; Latos-Grazyńska E; Ryczan R; Noworolska-Sauren D; Chybicka A J Interferon Cytokine Res; 2003 Apr; 23(4):173-81. PubMed ID: 12856329 [TBL] [Abstract][Full Text] [Related]
18. [Natural killer activity--an index of the efficacy of the treatment of patients with acute leukemia]. Gashchuk AP; Evtukh VP; Kindzel'skiĭ AL Lik Sprava; 1994; (5-6):79-81. PubMed ID: 7831919 [No Abstract] [Full Text] [Related]
19. Lymphocyte recovery and clinical response in multiple myeloma patients receiving interferon alpha 2 beta after intensive therapy. Millar BC; Bell JB; Powles RL Br J Cancer; 1996 Jan; 73(2):236-40. PubMed ID: 8546912 [TBL] [Abstract][Full Text] [Related]
20. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery. Kalwak K; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Latos-Grazyńska E; Król M; Boguslawska-Jaworska J; Chybicka A Br J Haematol; 2002 Jul; 118(1):74-89. PubMed ID: 12100130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]